GO:0008360 | regulation of cell shape | 2.93% (6/205) | 7.99 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 41.95% (86/205) | 1.07 | 0.0 | 0.0 |
GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity | 3.41% (7/205) | 6.29 | 0.0 | 0.0 |
GO:0022604 | regulation of cell morphogenesis | 2.93% (6/205) | 7.18 | 0.0 | 0.0 |
GO:0007010 | cytoskeleton organization | 5.85% (12/205) | 4.1 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 37.07% (76/205) | 1.07 | 0.0 | 0.0 |
GO:0022603 | regulation of anatomical structure morphogenesis | 2.93% (6/205) | 6.76 | 0.0 | 0.0 |
GO:0012506 | vesicle membrane | 3.9% (8/205) | 4.95 | 0.0 | 0.0 |
GO:0030659 | cytoplasmic vesicle membrane | 3.9% (8/205) | 4.95 | 0.0 | 0.0 |
GO:0046854 | phosphatidylinositol phosphate biosynthetic process | 3.41% (7/205) | 5.46 | 0.0 | 0.0 |
GO:0052742 | phosphatidylinositol kinase activity | 3.41% (7/205) | 5.54 | 0.0 | 0.0 |
GO:0016043 | cellular component organization | 12.2% (25/205) | 2.2 | 0.0 | 0.0 |
GO:0071840 | cellular component organization or biogenesis | 12.2% (25/205) | 2.05 | 0.0 | 0.0 |
GO:0010008 | endosome membrane | 3.41% (7/205) | 5.05 | 0.0 | 0.0 |
GO:0043227 | membrane-bounded organelle | 19.51% (40/205) | 1.47 | 0.0 | 0.0 |
GO:0005515 | protein binding | 20.0% (41/205) | 1.42 | 0.0 | 0.0 |
GO:0001727 | lipid kinase activity | 3.41% (7/205) | 4.81 | 0.0 | 0.0 |
GO:0006661 | phosphatidylinositol biosynthetic process | 3.41% (7/205) | 4.49 | 0.0 | 2e-06 |
GO:0043231 | intracellular membrane-bounded organelle | 18.54% (38/205) | 1.4 | 0.0 | 2e-06 |
GO:0051261 | protein depolymerization | 2.44% (5/205) | 5.77 | 0.0 | 2e-06 |
GO:0097435 | supramolecular fiber organization | 3.9% (8/205) | 4.04 | 0.0 | 2e-06 |
GO:0003674 | molecular_function | 53.66% (110/205) | 0.6 | 0.0 | 2e-06 |
GO:0008150 | biological_process | 45.37% (93/205) | 0.71 | 0.0 | 2e-06 |
GO:0009987 | cellular process | 34.15% (70/205) | 0.89 | 0.0 | 2e-06 |
GO:0050793 | regulation of developmental process | 2.93% (6/205) | 4.87 | 0.0 | 2e-06 |
GO:0043226 | organelle | 20.0% (41/205) | 1.29 | 0.0 | 2e-06 |
GO:0043229 | intracellular organelle | 20.0% (41/205) | 1.29 | 0.0 | 2e-06 |
GO:0005488 | binding | 39.02% (80/205) | 0.79 | 0.0 | 2e-06 |
GO:0007017 | microtubule-based process | 4.39% (9/205) | 3.48 | 0.0 | 4e-06 |
GO:0046474 | glycerophospholipid biosynthetic process | 3.41% (7/205) | 4.06 | 0.0 | 7e-06 |
GO:0043933 | protein-containing complex organization | 5.85% (12/205) | 2.7 | 0.0 | 1.2e-05 |
GO:0016272 | prefoldin complex | 1.46% (3/205) | 7.61 | 1e-06 | 1.3e-05 |
GO:0008092 | cytoskeletal protein binding | 4.88% (10/205) | 3.03 | 1e-06 | 1.3e-05 |
GO:0045017 | glycerolipid biosynthetic process | 3.41% (7/205) | 3.85 | 1e-06 | 1.7e-05 |
GO:0046488 | phosphatidylinositol metabolic process | 3.41% (7/205) | 3.82 | 1e-06 | 1.9e-05 |
GO:0008526 | phosphatidylinositol transfer activity | 1.46% (3/205) | 7.22 | 1e-06 | 2.7e-05 |
GO:0032984 | protein-containing complex disassembly | 2.44% (5/205) | 4.77 | 1e-06 | 2.8e-05 |
GO:0071501 | cellular response to sterol depletion | 0.98% (2/205) | 9.93 | 2e-06 | 3e-05 |
GO:0006991 | response to sterol depletion | 0.98% (2/205) | 9.93 | 2e-06 | 3e-05 |
GO:0015485 | cholesterol binding | 0.98% (2/205) | 9.93 | 2e-06 | 3e-05 |
GO:0032933 | SREBP signaling pathway | 0.98% (2/205) | 9.93 | 2e-06 | 3e-05 |
GO:0006984 | ER-nucleus signaling pathway | 0.98% (2/205) | 9.93 | 2e-06 | 3e-05 |
GO:0008654 | phospholipid biosynthetic process | 3.41% (7/205) | 3.69 | 2e-06 | 3.2e-05 |
GO:0031090 | organelle membrane | 5.85% (12/205) | 2.52 | 2e-06 | 3.3e-05 |
GO:0072319 | vesicle uncoating | 1.46% (3/205) | 6.84 | 3e-06 | 4.7e-05 |
GO:0072318 | clathrin coat disassembly | 1.46% (3/205) | 6.84 | 3e-06 | 4.7e-05 |
GO:0006457 | protein folding | 3.41% (7/205) | 3.52 | 3e-06 | 5.4e-05 |
GO:0006650 | glycerophospholipid metabolic process | 3.41% (7/205) | 3.49 | 4e-06 | 5.8e-05 |
GO:0005737 | cytoplasm | 10.24% (21/205) | 1.67 | 4e-06 | 5.9e-05 |
GO:0007021 | tubulin complex assembly | 1.46% (3/205) | 6.69 | 4e-06 | 5.9e-05 |
GO:0006897 | endocytosis | 2.44% (5/205) | 4.34 | 6e-06 | 8.7e-05 |
GO:0090407 | organophosphate biosynthetic process | 4.39% (9/205) | 2.85 | 6e-06 | 8.7e-05 |
GO:0006996 | organelle organization | 6.34% (13/205) | 2.17 | 9e-06 | 0.000127 |
GO:0005844 | polysome | 1.46% (3/205) | 6.24 | 1e-05 | 0.000134 |
GO:0046486 | glycerolipid metabolic process | 3.41% (7/205) | 3.29 | 1e-05 | 0.000135 |
GO:0015631 | tubulin binding | 3.41% (7/205) | 3.26 | 1.1e-05 | 0.000141 |
GO:0120014 | phospholipid transfer activity | 1.46% (3/205) | 6.21 | 1e-05 | 0.000142 |
GO:0120013 | lipid transfer activity | 1.46% (3/205) | 6.14 | 1.2e-05 | 0.000159 |
GO:0022411 | cellular component disassembly | 2.44% (5/205) | 4.02 | 1.7e-05 | 0.00022 |
GO:0000226 | microtubule cytoskeleton organization | 2.93% (6/205) | 3.5 | 1.9e-05 | 0.000236 |
GO:0004799 | thymidylate synthase activity | 0.98% (2/205) | 8.2 | 2.2e-05 | 0.000246 |
GO:0006231 | dTMP biosynthetic process | 0.98% (2/205) | 8.2 | 2.2e-05 | 0.000246 |
GO:0140674 | ATP-dependent histone chaperone activity | 0.98% (2/205) | 8.2 | 2.2e-05 | 0.000246 |
GO:0140849 | ATP-dependent H2AZ histone chaperone activity | 0.98% (2/205) | 8.2 | 2.2e-05 | 0.000246 |
GO:0140713 | histone chaperone activity | 0.98% (2/205) | 8.2 | 2.2e-05 | 0.000246 |
GO:0042083 | 5,10-methylenetetrahydrofolate-dependent methyltransferase activity | 0.98% (2/205) | 8.2 | 2.2e-05 | 0.000246 |
GO:0046073 | dTMP metabolic process | 0.98% (2/205) | 8.2 | 2.2e-05 | 0.000246 |
GO:0098657 | import into cell | 2.44% (5/205) | 3.96 | 2.1e-05 | 0.000259 |
GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process | 0.98% (2/205) | 7.99 | 2.9e-05 | 0.000309 |
GO:0009177 | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 0.98% (2/205) | 7.99 | 2.9e-05 | 0.000309 |
GO:0009162 | deoxyribonucleoside monophosphate metabolic process | 0.98% (2/205) | 7.99 | 2.9e-05 | 0.000309 |
GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process | 0.98% (2/205) | 7.99 | 2.9e-05 | 0.000309 |
GO:0051013 | microtubule severing | 0.98% (2/205) | 7.93 | 3.2e-05 | 0.000333 |
GO:0005548 | phospholipid transporter activity | 1.46% (3/205) | 5.62 | 3.5e-05 | 0.000363 |
GO:0046385 | deoxyribose phosphate biosynthetic process | 0.98% (2/205) | 7.71 | 4.4e-05 | 0.000426 |
GO:0009265 | 2'-deoxyribonucleotide biosynthetic process | 0.98% (2/205) | 7.71 | 4.4e-05 | 0.000426 |
GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process | 0.98% (2/205) | 7.71 | 4.4e-05 | 0.000426 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 0.98% (2/205) | 7.71 | 4.4e-05 | 0.000426 |
GO:0006644 | phospholipid metabolic process | 3.41% (7/205) | 2.89 | 5.4e-05 | 0.000524 |
GO:0031122 | cytoplasmic microtubule organization | 1.46% (3/205) | 5.39 | 5.6e-05 | 0.000525 |
GO:0005783 | endoplasmic reticulum | 3.41% (7/205) | 2.88 | 5.6e-05 | 0.00053 |
GO:0004146 | dihydrofolate reductase activity | 0.98% (2/205) | 7.39 | 6.8e-05 | 0.000637 |
GO:0006357 | regulation of transcription by RNA polymerase II | 3.9% (8/205) | 2.56 | 7.9e-05 | 0.000725 |
GO:0032991 | protein-containing complex | 11.22% (23/205) | 1.28 | 9e-05 | 0.000819 |
GO:0098588 | bounding membrane of organelle | 3.9% (8/205) | 2.52 | 9.3e-05 | 0.000835 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 0.98% (2/205) | 7.13 | 9.9e-05 | 0.000868 |
GO:0019692 | deoxyribose phosphate metabolic process | 0.98% (2/205) | 7.13 | 9.9e-05 | 0.000868 |
GO:0072583 | clathrin-dependent endocytosis | 1.46% (3/205) | 5.08 | 0.000106 | 0.000922 |
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 2.44% (5/205) | 3.42 | 0.000122 | 0.001025 |
GO:0004812 | aminoacyl-tRNA ligase activity | 2.44% (5/205) | 3.42 | 0.000122 | 0.001025 |
GO:0006418 | tRNA aminoacylation for protein translation | 2.44% (5/205) | 3.42 | 0.00012 | 0.001034 |
GO:0043039 | tRNA aminoacylation | 2.44% (5/205) | 3.39 | 0.000133 | 0.001106 |
GO:0019637 | organophosphate metabolic process | 4.88% (10/205) | 2.1 | 0.000139 | 0.001145 |
GO:0043038 | amino acid activation | 2.44% (5/205) | 3.34 | 0.000155 | 0.001257 |
GO:0072546 | EMC complex | 0.98% (2/205) | 6.68 | 0.000183 | 0.001468 |
GO:0006432 | phenylalanyl-tRNA aminoacylation | 0.98% (2/205) | 6.66 | 0.000189 | 0.001489 |
GO:0004826 | phenylalanine-tRNA ligase activity | 0.98% (2/205) | 6.66 | 0.000189 | 0.001489 |
GO:0065008 | regulation of biological quality | 2.93% (6/205) | 2.88 | 0.000193 | 0.001493 |
GO:0031982 | vesicle | 2.93% (6/205) | 2.88 | 0.000192 | 0.001494 |
GO:0006629 | lipid metabolic process | 5.85% (12/205) | 1.79 | 0.000225 | 0.001723 |
GO:0006898 | receptor-mediated endocytosis | 1.46% (3/205) | 4.68 | 0.000237 | 0.001796 |
GO:0140603 | obsolete ATP hydrolysis activity | 0.98% (2/205) | 6.47 | 0.000245 | 0.001834 |
GO:0009129 | pyrimidine nucleoside monophosphate metabolic process | 0.98% (2/205) | 6.45 | 0.000252 | 0.001836 |
GO:0009130 | pyrimidine nucleoside monophosphate biosynthetic process | 0.98% (2/205) | 6.45 | 0.000252 | 0.001836 |
GO:0005634 | nucleus | 9.27% (19/205) | 1.33 | 0.000249 | 0.001846 |
GO:0030276 | clathrin binding | 1.46% (3/205) | 4.64 | 0.00026 | 0.001859 |
GO:0034975 | protein folding in endoplasmic reticulum | 0.98% (2/205) | 6.43 | 0.00026 | 0.001873 |
GO:0031406 | carboxylic acid binding | 1.46% (3/205) | 4.61 | 0.000276 | 0.001933 |
GO:0043177 | organic acid binding | 1.46% (3/205) | 4.61 | 0.000276 | 0.001933 |
GO:0006419 | alanyl-tRNA aminoacylation | 0.98% (2/205) | 6.2 | 0.00036 | 0.002475 |
GO:0004813 | alanine-tRNA ligase activity | 0.98% (2/205) | 6.2 | 0.00036 | 0.002475 |
GO:0008352 | katanin complex | 0.98% (2/205) | 6.16 | 0.000378 | 0.002577 |
GO:0008610 | lipid biosynthetic process | 3.9% (8/205) | 2.21 | 0.000402 | 0.00272 |
GO:0043486 | obsolete histone exchange | 0.98% (2/205) | 6.04 | 0.000445 | 0.00298 |
GO:0000923 | equatorial microtubule organizing center | 0.98% (2/205) | 5.95 | 0.000506 | 0.003335 |
GO:0009263 | deoxyribonucleotide biosynthetic process | 0.98% (2/205) | 5.95 | 0.000506 | 0.003335 |
GO:0000930 | gamma-tubulin complex | 0.98% (2/205) | 5.83 | 0.000595 | 0.003883 |
GO:0043015 | gamma-tubulin binding | 0.98% (2/205) | 5.79 | 0.00063 | 0.004076 |
GO:0006399 | tRNA metabolic process | 2.93% (6/205) | 2.54 | 0.000658 | 0.004152 |
GO:0007020 | microtubule nucleation | 0.98% (2/205) | 5.76 | 0.000653 | 0.00416 |
GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | 0.98% (2/205) | 5.76 | 0.000653 | 0.00416 |
GO:0016872 | intramolecular lyase activity | 0.98% (2/205) | 5.75 | 0.000665 | 0.004167 |
GO:0140597 | protein carrier chaperone | 0.98% (2/205) | 5.66 | 0.000753 | 0.004565 |
GO:0051011 | microtubule minus-end binding | 0.98% (2/205) | 5.66 | 0.000753 | 0.004565 |
GO:0043178 | alcohol binding | 0.98% (2/205) | 5.65 | 0.000766 | 0.004607 |
GO:0046907 | intracellular transport | 3.9% (8/205) | 2.07 | 0.000744 | 0.00462 |
GO:0006575 | cellular modified amino acid metabolic process | 1.46% (3/205) | 4.11 | 0.000753 | 0.004638 |
GO:0009262 | deoxyribonucleotide metabolic process | 0.98% (2/205) | 5.62 | 0.000792 | 0.004727 |
GO:0005504 | fatty acid binding | 0.98% (2/205) | 5.54 | 0.000887 | 0.005172 |
GO:0007019 | microtubule depolymerization | 0.98% (2/205) | 5.54 | 0.000887 | 0.005172 |
GO:0005739 | mitochondrion | 3.41% (7/205) | 2.22 | 0.00088 | 0.005211 |
GO:0051649 | establishment of localization in cell | 3.9% (8/205) | 2.02 | 0.000924 | 0.005346 |
GO:0033554 | cellular response to stress | 4.39% (9/205) | 1.86 | 0.000981 | 0.005595 |
GO:0140658 | ATP-dependent chromatin remodeler activity | 1.46% (3/205) | 3.98 | 0.00098 | 0.005631 |
GO:0140101 | catalytic activity, acting on a tRNA | 2.44% (5/205) | 2.75 | 0.000995 | 0.005632 |
GO:0008568 | microtubule severing ATPase activity | 0.49% (1/205) | 9.93 | 0.001023 | 0.005705 |
GO:0140776 | protein-containing complex destabilizing activity | 0.49% (1/205) | 9.93 | 0.001023 | 0.005705 |
GO:0004707 | MAP kinase activity | 0.98% (2/205) | 5.42 | 0.001047 | 0.005794 |
GO:0006355 | regulation of DNA-templated transcription | 6.34% (13/205) | 1.44 | 0.001184 | 0.006283 |
GO:2001141 | regulation of RNA biosynthetic process | 6.34% (13/205) | 1.44 | 0.001184 | 0.006283 |
GO:0006520 | amino acid metabolic process | 3.41% (7/205) | 2.15 | 0.001171 | 0.006302 |
GO:0051716 | cellular response to stimulus | 4.39% (9/205) | 1.82 | 0.001199 | 0.006316 |
GO:0016864 | intramolecular oxidoreductase activity, transposing S-S bonds | 0.98% (2/205) | 5.31 | 0.001219 | 0.006336 |
GO:0003756 | protein disulfide isomerase activity | 0.98% (2/205) | 5.31 | 0.001219 | 0.006336 |
GO:0032934 | sterol binding | 0.98% (2/205) | 5.34 | 0.001171 | 0.006344 |
GO:0005496 | steroid binding | 0.98% (2/205) | 5.34 | 0.001171 | 0.006344 |
GO:0000922 | spindle pole | 0.98% (2/205) | 5.35 | 0.001155 | 0.006348 |
GO:0046653 | tetrahydrofolate metabolic process | 0.98% (2/205) | 5.27 | 0.001285 | 0.006633 |
GO:0005789 | endoplasmic reticulum membrane | 1.95% (4/205) | 3.09 | 0.001347 | 0.006909 |
GO:0044255 | cellular lipid metabolic process | 4.39% (9/205) | 1.79 | 0.001358 | 0.006916 |
GO:0044281 | small molecule metabolic process | 6.34% (13/205) | 1.42 | 0.001378 | 0.006974 |
GO:0031109 | microtubule polymerization or depolymerization | 0.98% (2/205) | 5.16 | 0.001493 | 0.007502 |
GO:0008289 | lipid binding | 2.44% (5/205) | 2.58 | 0.001654 | 0.008257 |
GO:0051641 | cellular localization | 4.39% (9/205) | 1.73 | 0.00182 | 0.00903 |
GO:0051252 | regulation of RNA metabolic process | 6.34% (13/205) | 1.37 | 0.001836 | 0.009052 |
GO:0033293 | monocarboxylic acid binding | 0.98% (2/205) | 4.89 | 0.002161 | 0.010585 |
GO:0016874 | ligase activity | 2.93% (6/205) | 2.16 | 0.002507 | 0.012201 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 6.34% (13/205) | 1.31 | 0.002576 | 0.012458 |
GO:0002161 | aminoacyl-tRNA editing activity | 0.98% (2/205) | 4.71 | 0.002752 | 0.013222 |
GO:0050789 | regulation of biological process | 10.24% (21/205) | 0.95 | 0.003103 | 0.014819 |
GO:0065007 | biological regulation | 10.73% (22/205) | 0.92 | 0.003322 | 0.015763 |
GO:0005319 | lipid transporter activity | 1.46% (3/205) | 3.35 | 0.003356 | 0.015828 |
GO:0098796 | membrane protein complex | 2.93% (6/205) | 2.07 | 0.003423 | 0.015851 |
GO:0006082 | organic acid metabolic process | 4.39% (9/205) | 1.59 | 0.003469 | 0.015869 |
GO:0019752 | carboxylic acid metabolic process | 4.39% (9/205) | 1.59 | 0.003388 | 0.015878 |
GO:0043436 | oxoacid metabolic process | 4.39% (9/205) | 1.59 | 0.003451 | 0.015882 |
GO:0140534 | endoplasmic reticulum protein-containing complex | 1.46% (3/205) | 3.34 | 0.003411 | 0.015889 |
GO:0006760 | folic acid-containing compound metabolic process | 0.98% (2/205) | 4.4 | 0.004162 | 0.018815 |
GO:0051179 | localization | 8.29% (17/205) | 1.04 | 0.004147 | 0.018859 |
GO:0016853 | isomerase activity | 2.44% (5/205) | 2.25 | 0.004326 | 0.019442 |
GO:0006810 | transport | 7.8% (16/205) | 1.07 | 0.00441 | 0.019589 |
GO:0051321 | meiotic cell cycle | 0.98% (2/205) | 4.36 | 0.004398 | 0.019651 |
GO:0042558 | pteridine-containing compound metabolic process | 0.98% (2/205) | 4.33 | 0.00458 | 0.020225 |
GO:0010468 | regulation of gene expression | 6.83% (14/205) | 1.15 | 0.004906 | 0.021542 |
GO:0030050 | vesicle transport along actin filament | 0.98% (2/205) | 4.22 | 0.005306 | 0.022522 |
GO:0099518 | vesicle cytoskeletal trafficking | 0.98% (2/205) | 4.22 | 0.005306 | 0.022522 |
GO:0099515 | actin filament-based transport | 0.98% (2/205) | 4.22 | 0.005306 | 0.022522 |
GO:0030048 | actin filament-based movement | 0.98% (2/205) | 4.22 | 0.005306 | 0.022522 |
GO:0010556 | regulation of macromolecule biosynthetic process | 6.83% (14/205) | 1.14 | 0.005198 | 0.022564 |
GO:0008017 | microtubule binding | 1.95% (4/205) | 2.55 | 0.005169 | 0.022568 |
GO:0051648 | vesicle localization | 0.98% (2/205) | 4.21 | 0.005405 | 0.022688 |
GO:0051650 | establishment of vesicle localization | 0.98% (2/205) | 4.21 | 0.005405 | 0.022688 |
GO:0000146 | microfilament motor activity | 0.98% (2/205) | 4.19 | 0.005537 | 0.023117 |
GO:0030705 | cytoskeleton-dependent intracellular transport | 0.98% (2/205) | 4.18 | 0.005604 | 0.023143 |
GO:0005856 | cytoskeleton | 1.46% (3/205) | 3.08 | 0.005598 | 0.023244 |
GO:0046524 | sucrose-phosphate synthase activity | 0.49% (1/205) | 7.43 | 0.005784 | 0.023629 |
GO:0043743 | LPPG:FO 2-phospho-L-lactate transferase activity | 0.49% (1/205) | 7.43 | 0.005784 | 0.023629 |
GO:0007015 | actin filament organization | 1.46% (3/205) | 3.06 | 0.005884 | 0.023911 |
GO:0031326 | regulation of cellular biosynthetic process | 6.83% (14/205) | 1.11 | 0.00604 | 0.024415 |
GO:0009889 | regulation of biosynthetic process | 6.83% (14/205) | 1.11 | 0.006077 | 0.024438 |
GO:0016459 | myosin complex | 0.98% (2/205) | 4.09 | 0.006328 | 0.025312 |
GO:0051015 | actin filament binding | 1.46% (3/205) | 3.01 | 0.006449 | 0.025663 |
GO:0022607 | cellular component assembly | 2.93% (6/205) | 1.86 | 0.006685 | 0.026328 |
GO:0051234 | establishment of localization | 7.8% (16/205) | 1.01 | 0.006678 | 0.026437 |
GO:0051171 | regulation of nitrogen compound metabolic process | 6.34% (13/205) | 1.13 | 0.007166 | 0.028076 |
GO:0016192 | vesicle-mediated transport | 2.93% (6/205) | 1.84 | 0.007264 | 0.028315 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 0.98% (2/205) | 3.96 | 0.007508 | 0.029117 |
GO:0009123 | nucleoside monophosphate metabolic process | 0.98% (2/205) | 3.96 | 0.007546 | 0.029118 |
GO:0000049 | tRNA binding | 0.98% (2/205) | 3.96 | 0.007585 | 0.02912 |
GO:0051213 | dioxygenase activity | 1.46% (3/205) | 2.91 | 0.007746 | 0.029442 |
GO:0080090 | regulation of primary metabolic process | 6.34% (13/205) | 1.12 | 0.00772 | 0.029491 |
GO:0005759 | mitochondrial matrix | 0.98% (2/205) | 3.93 | 0.007817 | 0.029567 |
GO:0050794 | regulation of cellular process | 9.27% (19/205) | 0.88 | 0.008161 | 0.030565 |
GO:1901576 | organic substance biosynthetic process | 6.83% (14/205) | 1.06 | 0.00814 | 0.030635 |
GO:0018208 | peptidyl-proline modification | 0.98% (2/205) | 3.89 | 0.008292 | 0.030753 |
GO:0040008 | regulation of growth | 0.98% (2/205) | 3.89 | 0.008252 | 0.030754 |
GO:0015931 | nucleobase-containing compound transport | 1.46% (3/205) | 2.84 | 0.008929 | 0.032956 |
GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors | 0.98% (2/205) | 3.81 | 0.009195 | 0.033294 |
GO:0060589 | nucleoside-triphosphatase regulator activity | 1.46% (3/205) | 2.82 | 0.009186 | 0.033419 |
GO:0030695 | GTPase regulator activity | 1.46% (3/205) | 2.82 | 0.009186 | 0.033419 |
GO:0005813 | centrosome | 0.98% (2/205) | 3.81 | 0.009153 | 0.03362 |
GO:0003779 | actin binding | 1.46% (3/205) | 2.75 | 0.010447 | 0.036952 |
GO:0006220 | pyrimidine nucleotide metabolic process | 0.98% (2/205) | 3.72 | 0.010405 | 0.036973 |
GO:0005875 | microtubule associated complex | 0.98% (2/205) | 3.72 | 0.010405 | 0.036973 |
GO:0006221 | pyrimidine nucleotide biosynthetic process | 0.98% (2/205) | 3.72 | 0.01036 | 0.037161 |
GO:0031625 | ubiquitin protein ligase binding | 0.98% (2/205) | 3.72 | 0.01036 | 0.037161 |
GO:0044389 | ubiquitin-like protein ligase binding | 0.98% (2/205) | 3.68 | 0.010853 | 0.03821 |
GO:0060255 | regulation of macromolecule metabolic process | 6.83% (14/205) | 1.01 | 0.011019 | 0.038616 |
GO:0051028 | mRNA transport | 0.98% (2/205) | 3.65 | 0.011402 | 0.039595 |
GO:0006406 | mRNA export from nucleus | 0.98% (2/205) | 3.65 | 0.011402 | 0.039595 |
GO:0031323 | regulation of cellular metabolic process | 6.83% (14/205) | 1.0 | 0.011564 | 0.039796 |
GO:0043167 | ion binding | 15.61% (32/205) | 0.6 | 0.011512 | 0.039799 |
GO:0005815 | microtubule organizing center | 0.98% (2/205) | 3.63 | 0.011634 | 0.039858 |
GO:0036094 | small molecule binding | 12.2% (25/205) | 0.7 | 0.011753 | 0.040087 |
GO:0009058 | biosynthetic process | 6.83% (14/205) | 0.98 | 0.012369 | 0.042 |
GO:0051225 | spindle assembly | 0.98% (2/205) | 3.57 | 0.012584 | 0.04254 |
GO:0000346 | transcription export complex | 0.49% (1/205) | 6.27 | 0.012882 | 0.043357 |
GO:0000278 | mitotic cell cycle | 0.98% (2/205) | 3.54 | 0.013071 | 0.043799 |
GO:0004814 | arginine-tRNA ligase activity | 0.49% (1/205) | 6.23 | 0.013219 | 0.04391 |
GO:0006420 | arginyl-tRNA aminoacylation | 0.49% (1/205) | 6.23 | 0.013219 | 0.04391 |
GO:0043233 | organelle lumen | 0.98% (2/205) | 3.5 | 0.013766 | 0.04514 |
GO:0031974 | membrane-enclosed lumen | 0.98% (2/205) | 3.5 | 0.013766 | 0.04514 |
GO:0070013 | intracellular organelle lumen | 0.98% (2/205) | 3.5 | 0.013766 | 0.04514 |
GO:0043541 | UDP-N-acetylglucosamine transferase complex | 0.49% (1/205) | 6.16 | 0.013892 | 0.045357 |
GO:0070905 | serine binding | 0.49% (1/205) | 6.13 | 0.014228 | 0.045867 |
GO:0004372 | glycine hydroxymethyltransferase activity | 0.49% (1/205) | 6.13 | 0.014228 | 0.045867 |
GO:0019264 | glycine biosynthetic process from serine | 0.49% (1/205) | 6.13 | 0.014228 | 0.045867 |
GO:0016860 | intramolecular oxidoreductase activity | 0.98% (2/205) | 3.46 | 0.014478 | 0.046475 |
GO:0019222 | regulation of metabolic process | 6.83% (14/205) | 0.95 | 0.014836 | 0.047425 |
GO:0033180 | proton-transporting V-type ATPase, V1 domain | 0.49% (1/205) | 6.06 | 0.014901 | 0.047435 |
GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | 0.98% (2/205) | 3.41 | 0.015574 | 0.049371 |
GO:0015629 | actin cytoskeleton | 0.98% (2/205) | 3.4 | 0.01568 | 0.049503 |